$RKLB
Rocket Lab USA, Inc. Stock $rklb

$rklb Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024022160 Filed on February 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$92.77M	$59.99M	$244.6M
YoY Change	68.99%	15.9%	15.92%
Cost Of Revenue	$68.59M	$44.50M	$193.2M
YoY Change	41.32%	-10.88%	0.61%
Gross Profit	$24.17M	$15.49M	$51.41M
YoY Change	280.27%	746.56%	170.72%
Gross Profit Margin	26.06%	25.82%	21.02%
Selling, General & Admin	$28.75M	$23.77M	$110.3M
YoY Change	0.98%	8.12%	23.87%
% of Gross Profit	118.93%	153.4%	214.5%
Research & Development	$38.50M	$35.79M	$119.1M
YoY Change	61.07%	148.9%	82.69%
% of Gross Profit	159.28%	231.0%	231.58%
Depreciation & Amortization	$4.765M	$8.167M	$15.41M
YoY Change	33.92%	-2.27%	-4.65%
% of Gross Profit	19.71%	52.72%	29.97%
Operating Expenses	$67.25M	$63.37M	$229.3M
YoY Change	28.41%	62.28%	48.73%
Operating Profit	-$43.08M	-$47.88M	-$177.9M
YoY Change	-6.38%	28.64%	31.59%
Interest Expense	-$898.0K	-$1.799M	-$4.248M
YoY Change	31.09%	30.36%	-45.53%
% of Operating Profit
Other Income/Expense, Net	-$1.176M	$196.0K	-$1.003M
YoY Change	-227.0%	-49.09%	-144.42%
Pretax Income	-$44.26M	-$49.49M	-$178.9M
YoY Change	-1.85%	29.48%	34.58%
Income Tax	$5.000K	$1.011M	$3.650M
% Of Pretax Income
Net Earnings	-$44.26M	-$50.50M	-$182.6M
YoY Change	-2.97%	35.72%	34.3%
Net Earnings / Revenue	-47.71%	-84.17%	-74.64%
Basic Earnings Per Share	-$0.09		-$0.38
Diluted Earnings Per Share	-$0.09	-$0.10	-$0.38
COMMON SHARES
Basic Shares Outstanding	489.1M	485.9M	481.8M
Diluted Shares Outstanding	490.0M		481.8M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$561.1M	$324.0M	$244.8M
YoY Change	25.62%	-32.63%	-48.12%
Cash & Equivalents	$365.9M	$162.5M	$162.5M
Short-Term Investments	$195.2M	$161.5M	$82.26M
Other Short-Term Assets	$5.782M	$5.245M	$62.29M
YoY Change	-6.09%	-31.28%	22.72%
Inventory	$99.90M	$107.9M	$107.9M
Prepaid Expenses	$59.46M	$48.03M
Receivables	$31.17M	$35.18M	$48.13M
Other Receivables	$13.36M	$13.67M	$13.67M
Total Short-Term Assets	$725.6M	$476.7M	$476.7M
YoY Change	14.23%	-28.02%	-28.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$148.1M	$145.4M	$219.8M
YoY Change	54.29%	43.24%	44.25%
Goodwill	$71.02M	$71.02M
YoY Change	0.0%	0.0%
Intangibles	$66.85M	$68.09M
YoY Change	-12.62%	-14.55%
Long-Term Investments	$68.57M	$79.25M	$79.25M
YoY Change	43.08%	762.04%	762.04%
Other Assets	$22.88M	$18.91M	$26.33M
YoY Change	222.22%	158.99%	80.88%
Total Long-Term Assets	$456.3M	$464.5M	$464.5M
YoY Change	28.3%	42.12%	42.12%
TOTAL ASSETS
Total Short-Term Assets	$725.6M	$476.7M	$476.7M
Total Long-Term Assets	$456.3M	$464.5M	$464.5M
Total Assets	$1.182B	$941.2M	$941.2M
YoY Change	19.28%	-4.84%	-4.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.00M	$29.30M	$29.30M
YoY Change	13.75%	142.49%	142.49%
Accrued Expenses	$9.091M	$5.590M	$10.87M
YoY Change	4.76%	-35.92%	-10.28%
Deferred Revenue	$150.5M	$139.3M
YoY Change	19.82%	28.61%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.00M	$17.76M	$18.09M
YoY Change	274.78%	511.29%	458.08%
Total Short-Term Liabilities	$232.5M	$223.4M	$223.4M
YoY Change	17.82%	37.09%	37.09%
LONG-TERM LIABILITIES
Long-Term Debt	$52.72M	$87.59M	$102.8M
YoY Change	-47.66%	-12.45%	-11.06%
Other Long-Term Liabilities	$4.162M	$3.944M	$60.04M
YoY Change	24.13%	31.25%	61.1%
Total Long-Term Liabilities	$56.88M	$91.53M	$162.9M
YoY Change	-45.35%	-11.18%	6.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$232.5M	$223.4M	$223.4M
Total Long-Term Liabilities	$56.88M	$91.53M	$162.9M
Total Liabilities	$703.0M	$386.7M	$386.7M
YoY Change	100.34%	22.4%	22.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$667.8M	-$623.5M
YoY Change	37.24%	41.4%
Common Stock	$49.00K	$49.00K
YoY Change	2.08%	2.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$478.9M	$554.5M	$554.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.182B	$941.2M	$941.2M
YoY Change	19.28%	-4.84%	-4.84%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$44.26M	-$50.50M	-$182.6M
YoY Change	-2.97%	35.72%	34.3%
Depreciation, Depletion And Amortization	$4.765M	$8.167M	$15.41M
YoY Change	33.92%	-2.27%	-4.65%
Cash From Operating Activities	-$2.588M	-$42.22M	-$98.87M
YoY Change	-89.81%	122.83%	-7.2%
INVESTING ACTIVITIES
Capital Expenditures	$19.18M	$10.41M	$54.71M
YoY Change	51.31%	-30.54%	28.99%
Acquisitions			$18.97M
YoY Change			-71.19%
Other Investing Activities	-$33.08M	$71.59M	$66.72M
YoY Change	-2040.12%	-222.93%	-121.97%
Cash From Investing Activities	-$52.26M	$61.17M	$12.02M
YoY Change	376.4%	-183.54%	-103.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	258.7M	2.506M	7.369M
YoY Change	12470.8%	430.93%	261.05%
NET CHANGE
Cash From Operating Activities	-2.588M	-42.22M	-98.87M
Cash From Investing Activities	-52.26M	61.17M	12.02M
Cash From Financing Activities	258.7M	2.506M	7.369M
Net Change In Cash	203.3M	21.46M	-79.44M
YoY Change	-695.11%	-123.4%	-82.2%
FREE CASH FLOW
Cash From Operating Activities	-$2.588M	-$42.22M	-$98.87M
Capital Expenditures	$19.18M	$10.41M	$54.71M
Free Cash Flow	-$21.77M	-$52.63M	-$153.6M
YoY Change	-42.81%	55.08%	3.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001819994
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration	http://fasb.org/us-gaap/2023#LesseeOperatingLeaseRemainingLeaseTerm
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#FairValueAdjustmentOfWarrants
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FinanceLeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FinanceLeaseLiabilityNoncurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39560
CY2023	dei	Entity Registrant Name EntityRegistrantName	ROCKET LAB USA, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1550340
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3881 McGowen Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Long Beach
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90808
CY2023	dei	City Area Code CityAreaCode	714
CY2023	dei	Local Phone Number LocalPhoneNumber	465-5737
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1761100000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7303000
CY2023Q4	us-gaap	Assets Assets	941211000
CY2022Q4	us-gaap	Assets Assets	989123000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	29303000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	489140411
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	162518000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	242515000
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	82255000
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	229276000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35176000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36572000
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	12951000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	9451000
CY2023Q4	us-gaap	Inventory Net InventoryNet	107857000
CY2022Q4	us-gaap	Inventory Net InventoryNet	92279000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66949000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	52201000
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	9016000
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0
CY2023Q4	us-gaap	Assets Current AssetsCurrent	476722000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	662294000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145409000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101514000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	68094000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79692000
CY2023Q4	us-gaap	Goodwill Goodwill	71020000
CY2022Q4	us-gaap	Goodwill Goodwill	71020000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59401000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35239000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14987000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	15614000
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	79247000
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	9193000
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3916000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3356000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3501000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3898000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18914000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12084000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5590000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8723000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16342000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8634000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	139338000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	108344000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	17764000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2906000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15036000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22249000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	223373000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	162940000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	87587000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100043000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56099000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34266000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15238000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15568000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	426000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	95000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3944000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3005000
CY2023Q4	us-gaap	Liabilities Liabilities	386667000
CY2022Q4	us-gaap	Liabilities Liabilities	315917000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	488923055
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	488923055
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	475356517
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	475356517
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	49000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	48000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1176484000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1112977000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-623526000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-440955000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1537000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1136000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	554544000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	673206000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	941211000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	989123000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	244592000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	210996000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62237000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	193183000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	192006000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	64130000
CY2023	us-gaap	Gross Profit GrossProfit	51409000
CY2022	us-gaap	Gross Profit GrossProfit	18990000
CY2021	us-gaap	Gross Profit GrossProfit	-1893000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	119054000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65168000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41765000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	110273000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	89026000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	58395000
CY2023	us-gaap	Operating Expenses OperatingExpenses	229327000
CY2022	us-gaap	Operating Expenses OperatingExpenses	154194000
CY2021	us-gaap	Operating Expenses OperatingExpenses	100160000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-177918000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-135204000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-102053000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4248000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-7799000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-6128000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-470000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4435000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-567000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-13482000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15294000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3715000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1010000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-798000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1003000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2258000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22787000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-178921000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-132946000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-124840000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3650000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2998000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7520000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-182571000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-135944000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-117320000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-93000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	600000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	253000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	494000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-772000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-182170000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-136116000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-117067000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	481768060
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	481768060
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	466214095
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	466214095
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	209895135
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	209895135
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-166708000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-117320000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3122000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	33108000
CY2021	rklb	Stock Issued During Period Value Preferred Stock Warrants Exercised StockIssuedDuringPeriodValuePreferredStockWarrantsExercised	6514000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2975000
CY2021	rklb	Conversion Of Public Warrants For Common Stock ConversionOfPublicWarrantsForCommonStock	35000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	274961000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11568000
CY2021	rklb	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	649940000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	253000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	698448000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-135944000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7627000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	58403000
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	44844000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-172000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	673206000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-182571000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7423000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	51403000
CY2023	rklb	Stock Issued During Period In Connection With Loan Agreement Value Common Stock Warrant StockIssuedDuringPeriodInConnectionWithLoanAgreementValueCommonStockWarrant	2595000
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2087000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	401000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	554544000
CY2023	us-gaap	Profit Loss ProfitLoss	-182571000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4548000
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	15585000
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2129000
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4517000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3275000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3518000
CY2022	us-gaap	Profit Loss ProfitLoss	-135944000
CY2021	us-gaap	Profit Loss ProfitLoss	-117320000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29744000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29947000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10851000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	53461000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	55649000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	32557000
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	111000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-923000
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-156000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1732000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-496000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2904000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2827000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1546000
CY2023	rklb	Non Cash Lease Expense NonCashLeaseExpense	5787000
CY2022	rklb	Non Cash Lease Expense NonCashLeaseExpense	3199000
CY2021	rklb	Non Cash Lease Expense NonCashLeaseExpense	2010000
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-13482000
CY2021	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	15294000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1343000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4571000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1395000
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	708000
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-576000
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-9979000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1452000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9430000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7789000
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	3501000
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	7545000
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-1816000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15562000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25964000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12072000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14586000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15059000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10504000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	11470000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7072000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3074000
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5484000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2108000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-326000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	30992000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	22661000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	28057000
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-7563000
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1280000
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	838000
CY2023	rklb	Increase Decrease In Non Current Lease Liabilities IncreaseDecreaseInNonCurrentLeaseLiabilities	-5076000
CY2022	rklb	Increase Decrease In Non Current Lease Liabilities IncreaseDecreaseInNonCurrentLeaseLiabilities	-3686000
CY2021	rklb	Increase Decrease In Non Current Lease Liabilities IncreaseDecreaseInNonCurrentLeaseLiabilities	-1801000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	227000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	668000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	370000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-98867000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-106538000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71791000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54707000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42412000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25699000
CY2023	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-3660000
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0
CY2021	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	18966000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	65824000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	66435000
CY2023	rklb	Purchases Of Marketable Securities PurchasesOfMarketableSecurities	207266000
CY2022	rklb	Purchases Of Marketable Securities PurchasesOfMarketableSecurities	259567000
CY2021	rklb	Purchases Of Marketable Securities PurchasesOfMarketableSecurities	0
CY2023	rklb	Maturities Of Marketable Securities MaturitiesOfMarketableSecurities	-269204000
CY2022	rklb	Maturities Of Marketable Securities MaturitiesOfMarketableSecurities	-21724000
CY2021	rklb	Maturities Of Marketable Securities MaturitiesOfMarketableSecurities	0
CY2023	rklb	Sale Of Marketable Securities SaleOfMarketableSecurities	-20093000
CY2022	rklb	Sale Of Marketable Securities SaleOfMarketableSecurities	0
CY2021	rklb	Sale Of Marketable Securities SaleOfMarketableSecurities	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12018000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-346079000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-92134000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2444000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3874000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3147000
CY2023	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	4988000
CY2022	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	4380000
CY2021	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	0
CY2023	rklb	Proceeds From Sale Of Employees Restricted Stock Units To Cover Taxes ProceedsFromSaleOfEmployeesRestrictedStockUnitsToCoverTaxes	15995000
CY2022	rklb	Proceeds From Sale Of Employees Restricted Stock Units To Cover Taxes ProceedsFromSaleOfEmployeesRestrictedStockUnitsToCoverTaxes	31166000
CY2021	rklb	Proceeds From Sale Of Employees Restricted Stock Units To Cover Taxes ProceedsFromSaleOfEmployeesRestrictedStockUnitsToCoverTaxes	0
CY2023	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	15722000
CY2022	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	31164000
CY2021	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	0
CY2023	rklb	Tax Payment For Net Settled Option Shares TaxPaymentForNetSettledOptionShares	0
CY2022	rklb	Tax Payment For Net Settled Option Shares TaxPaymentForNetSettledOptionShares	444000
CY2021	rklb	Tax Payment For Net Settled Option Shares TaxPaymentForNetSettledOptionShares	0
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1000000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5500000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	336000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	271000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0
CY2023	rklb	Proceeds From Long Term Revolving Line Of Credit ProceedsFromLongTermRevolvingLineOfCredit	0
CY2022	rklb	Proceeds From Long Term Revolving Line Of Credit ProceedsFromLongTermRevolvingLineOfCredit	0
CY2021	rklb	Proceeds From Long Term Revolving Line Of Credit ProceedsFromLongTermRevolvingLineOfCredit	-15000000
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	110000000
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	98895000
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	107573000
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1427000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	15000000
CY2023	rklb	Proceeds From Business Combination And Pipe Investment Net Of Transaction Costs ProceedsFromBusinessCombinationAndPipeInvestmentNetOfTransactionCosts	0
CY2022	rklb	Proceeds From Business Combination And Pipe Investment Net Of Transaction Costs ProceedsFromBusinessCombinationAndPipeInvestmentNetOfTransactionCosts	0
CY2021	rklb	Proceeds From Business Combination And Pipe Investment Net Of Transaction Costs ProceedsFromBusinessCombinationAndPipeInvestmentNetOfTransactionCosts	728255000
CY2023	rklb	Repurchase Of Shares And Options From Management RepurchaseOfSharesAndOptionsFromManagement	0
CY2022	rklb	Repurchase Of Shares And Options From Management RepurchaseOfSharesAndOptionsFromManagement	0
CY2021	rklb	Repurchase Of Shares And Options From Management RepurchaseOfSharesAndOptionsFromManagement	30358000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7369000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2041000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	799939000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4372000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2128000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-79437000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-446204000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	638142000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	245871000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	692075000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53933000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166434000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	245871000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	692075000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	15553000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	10749000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	3991000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-769000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2666000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1842000
CY2023	rklb	Unpaid Purchases Of Property Equipment And Software UnpaidPurchasesOfPropertyEquipmentAndSoftware	2796000
CY2022	rklb	Unpaid Purchases Of Property Equipment And Software UnpaidPurchasesOfPropertyEquipmentAndSoftware	1865000
CY2021	rklb	Unpaid Purchases Of Property Equipment And Software UnpaidPurchasesOfPropertyEquipmentAndSoftware	938000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	30396000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9140000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3916000
CY2023	rklb	Early Termination Of Right Of Use Assets EarlyTerminationOfRightOfUseAssets	664000
CY2022	rklb	Early Termination Of Right Of Use Assets EarlyTerminationOfRightOfUseAssets	0
CY2021	rklb	Early Termination Of Right Of Use Assets EarlyTerminationOfRightOfUseAssets	0
CY2023	rklb	Net Exercise Of Public And Private Warrants Into Common Stock NetExerciseOfPublicAndPrivateWarrantsIntoCommonStock	0
CY2022	rklb	Net Exercise Of Public And Private Warrants Into Common Stock NetExerciseOfPublicAndPrivateWarrantsIntoCommonStock	44739000
CY2021	rklb	Net Exercise Of Public And Private Warrants Into Common Stock NetExerciseOfPublicAndPrivateWarrantsIntoCommonStock	0
CY2023	rklb	Issuance Of Common Stock For Payment Of Accrued Bonus IssuanceOfCommonStockForPaymentOfAccruedBonus	0
CY2022	rklb	Issuance Of Common Stock For Payment Of Accrued Bonus IssuanceOfCommonStockForPaymentOfAccruedBonus	1441000
CY2021	rklb	Issuance Of Common Stock For Payment Of Accrued Bonus IssuanceOfCommonStockForPaymentOfAccruedBonus	0
CY2023	rklb	Issuance Of Common Stock Warrants And Accrued Issuance Costs Connection With Loan And Security Agreement IssuanceOfCommonStockWarrantsAndAccruedIssuanceCostsConnectionWithLoanAndSecurityAgreement	2595000
CY2022	rklb	Issuance Of Common Stock Warrants And Accrued Issuance Costs Connection With Loan And Security Agreement IssuanceOfCommonStockWarrantsAndAccruedIssuanceCostsConnectionWithLoanAndSecurityAgreement	0
CY2021	rklb	Issuance Of Common Stock Warrants And Accrued Issuance Costs Connection With Loan And Security Agreement IssuanceOfCommonStockWarrantsAndAccruedIssuanceCostsConnectionWithLoanAndSecurityAgreement	0
CY2023	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding	0
CY2022	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding	0
CY2021	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding	48149000
CY2023	rklb	Contingent Consideration Assumed At Acquisitions ContingentConsiderationAssumedAtAcquisitions	0
CY2022	rklb	Contingent Consideration Assumed At Acquisitions ContingentConsiderationAssumedAtAcquisitions	0
CY2021	rklb	Contingent Consideration Assumed At Acquisitions ContingentConsiderationAssumedAtAcquisitions	-7300000
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2087000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11568000
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	0
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	0
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	219000
CY2023	rklb	Accrued Issuance Costs In Connection With Debt Issuance AccruedIssuanceCostsInConnectionWithDebtIssuance	641000
CY2022	rklb	Accrued Issuance Costs In Connection With Debt Issuance AccruedIssuanceCostsInConnectionWithDebtIssuance	0
CY2021	rklb	Accrued Issuance Costs In Connection With Debt Issuance AccruedIssuanceCostsInConnectionWithDebtIssuance	0
CY2023	rklb	Unpaid Transaction Costs UnpaidTransactionCosts	0
CY2022	rklb	Unpaid Transaction Costs UnpaidTransactionCosts	0
CY2021	rklb	Unpaid Transaction Costs UnpaidTransactionCosts	27000
CY2021Q3	us-gaap	Shares Outstanding SharesOutstanding	447919591
CY2021Q4	us-gaap	Cash Cash	310330000
CY2021Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	49075000
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	728255000
CY2021Q4	rklb	Accrued Transaction Costs AccruedTransactionCosts	27000
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	219000
CY2021	rklb	Warrants And Right Outstanding WarrantsAndRightOutstanding	48149000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	30358000
CY2021	rklb	Reverse Recapitalization Net Of Transaction Costs ReverseRecapitalizationNetOfTransactionCosts	649940000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	rklb	Stockholders Equity Note Stock Splitexchange Ratio StockholdersEquityNoteStockSplitexchangeRatio	9.059659
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On an ongoing basis, our management evaluates estimates and assumptions including those related to revenue recognition, contract costs, loss reserves, valuation of warrants and stock-based compensation and deferred tax valuation allowances. We based our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Actual results could differ from these estimates and assumptions.</span></p>
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3916000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3356000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	rklb	Percentage Of Tax Incentive Reimburse PercentageOfTaxIncentiveReimburse	0.15
CY2023	rklb	Proceeds From Research And Development ProceedsFromResearchAndDevelopment	20339000
CY2022	rklb	Proceeds From Research And Development ProceedsFromResearchAndDevelopment	3618000
CY2021	rklb	Proceeds From Research And Development ProceedsFromResearchAndDevelopment	393000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Forfeitures are recognized as incurred for as they occur. Unless otherwise approved, options must be exercised while the individual is an employee or within 90-days of termination when applicable. The expiration date of newly issued options is ten years after grant date unless earlier terminated as provided for in the Plan.
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	244592000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	210996000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	62237000
CY2023Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	35176000
CY2022Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	36572000
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	12951000
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	9451000
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	139338000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	108344000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	108344000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	59749000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26132000
CY2023	rklb	Contract Liabilities Assumed At Acquisition ContractLiabilitiesAssumedAtAcquisition	0
CY2022	rklb	Contract Liabilities Assumed At Acquisition ContractLiabilitiesAssumedAtAcquisition	26014000
CY2021	rklb	Contract Liabilities Assumed At Acquisition ContractLiabilitiesAssumedAtAcquisition	5560000
CY2023	rklb	Contract With Customer Liability Current Additions1 ContractWithCustomerLiabilityCurrentAdditions1	137158000
CY2022	rklb	Contract With Customer Liability Current Additions1 ContractWithCustomerLiabilityCurrentAdditions1	96206000
CY2021	rklb	Contract With Customer Liability Current Additions1 ContractWithCustomerLiabilityCurrentAdditions1	41614000
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	106164000
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	73625000
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	13557000
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	139338000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	108344000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	59749000
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1046126000
CY2023	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	approximately 41% is expected to be recognized within 12 months, with the remaining 59% to be recognized beyond 12 months.
CY2023	rklb	Customer Financing Interest Income CustomerFinancingInterestIncome	371000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	283270000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	92000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	369000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	282993000
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	121491000
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	161502000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	98159000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	351000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	3536000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	18000
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	101695000
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	369000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	50661000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	283270000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	282993000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3899000
CY2021	rklb	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cost Of Warrants Vesting FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCostOfWarrantsVesting	352000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	5238000
CY2021	rklb	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Warrants To Purchase FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfWarrantsToPurchase	-6514000
CY2021	rklb	Fairvalue Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exchange Of Warrants To Purchase FairvalueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExchangeOfWarrantsToPurchase	-2975000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	45062000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	33376000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	53628000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9167000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8242000
CY2023Q4	us-gaap	Inventory Net InventoryNet	107857000
CY2022Q4	us-gaap	Inventory Net InventoryNet	92279000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	48031000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	43126000
CY2023Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	9940000
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	1443000
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3733000
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5245000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7632000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66949000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	52201000
CY2023Q4	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	3900000
CY2023Q4	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	1094000
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	9016000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	194519000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	137903000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49110000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36389000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145409000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101514000
CY2023	us-gaap	Depreciation Depreciation	15407000
CY2022	us-gaap	Depreciation Depreciation	16158000
CY2021	us-gaap	Depreciation Depreciation	7530000
CY2021Q4	us-gaap	Goodwill Goodwill	43308000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	25902000
CY2022	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	1810000
CY2022Q4	us-gaap	Goodwill Goodwill	71020000
CY2023Q4	us-gaap	Goodwill Goodwill	71020000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	101009000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32915000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	68094000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	99482000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19790000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	79692000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13100000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13227000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3321000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12323000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9447000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9256000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	8278000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7322000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	19168000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65794000
CY2023	us-gaap	Line Of Credit Facility Borrowing Capacity Description LineOfCreditFacilityBorrowingCapacityDescription	On December 29, 2023 (the “Effective Date”), the Company and certain of its subsidiaries (the “Subsidiaries”, together with the Company, the “Borrowers”), entered into a Master Equipment Financing Agreement (the “Loan Agreement”) with Trinity Capital, Inc., a Maryland corporation (the “Lender”) to provide financing for certain equipment and other property (the “Equipment”). The Loan Agreement provides that the Lender shall provide equipment financing in the aggregate of up to $120,000 (the “Conditional Commitment”), with advances (“Draws”) to be made as follows: (i) $70,000 on the Effective Date (the “Effective Date Draw”); and (ii) $40,000 to be drawn on the Effective Date (the “Blanket Lien Draw”), with each of the Effective Date Draw and Blanket Lien Draw payable over sixty (60) months beginning January 2024, with the final payments due in January 2029. After the Blanket Lien Draw is repaid in full, Borrowers may make Draws as follows: (x) $30,000 to be drawn in not more than three advances of at least $10,000 each at the Borrowers’ option no later than the date that is 18 months after the Effective Date; and (y) $20,000 to be drawn at Borrower’s option between January 1, 2025 and June 30, 2025 (such date, the “Termination Date”), subject to customary conditions.
CY2023	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	The monthly payment factors under the Loan Agreement and Blanket Lien Draw have a term of sixty (60) months and a rate factor of 0.022266.
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	110000000
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4649000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	17764000
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.144
CY2023Q4	rklb	Term Charge On Repayment Of Debt TermChargeOnRepaymentOfDebt	700000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	17764000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	18969000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	21470000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	24301000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	27496000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	110000000
CY2021Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000000
CY2021Q2	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1000000
CY2023Q4	rklb	Line Of Credit Facility Front End Fee Amount LineOfCreditFacilityFrontEndFeeAmount	3250000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1732000
CY2023	rklb	Schedule Of Assumptions In Black Sholes Pricing Model Calculation For The Warrant Issued ScheduleOfAssumptionsInBlackSholesPricingModelCalculationForTheWarrantIssued	<p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used in the Black-Sholes pricing model calculation for the Warrant issued:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:75.727%;"></td> <td style="width:2.12%;"></td> <td style="width:1%;"></td> <td style="width:20.153%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Share price</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.53</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Strike price</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.87</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">82.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.85</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected life (years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dividend rate</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">None</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table>
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53461000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	55649000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32557000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22088726
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.53
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	85853000
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3708786
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisedDateFairValue	0.51
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriodWeightedAverageRemainingContractualTerm2	P4Y3M25D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	41822000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	857579
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.21
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Forfeited Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageForfeitedDateFairValue	0.6
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageRemainingContractualTerm2	P0Y3D
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue	9131000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	177033
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.16
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Weighted Average Expired Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExpiredDateFairValue	0.31
CY2021	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue	1969000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17345328
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.54
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	195111000
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3887435
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.02
CY2022	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisedDateFairValue	0.51
CY2022	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriodWeightedAverageRemainingContractualTerm2	P1Y11M4D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10687000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	200173
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.22
CY2022	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Forfeited Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageForfeitedDateFairValue	0.71
CY2022	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue	510000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13257720
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.53
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	36306000
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2623282
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.93
CY2023	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisedDateFairValue	0.47
CY2023	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriodWeightedAverageRemainingContractualTerm2	P0Y10M9D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12072000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7556
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.42
CY2023	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Forfeited Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageForfeitedDateFairValue	0.78
CY2023	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue	31000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	75596
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.22
CY2023	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Weighted Average Expired Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExpiredDateFairValue	0.72
CY2023	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue	326000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10551286
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.06
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.53
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M25D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47210000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	10551286
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.06
CY2023Q4	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.53
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y3M25D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	47210000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	13185026
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.03
CY2022Q4	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.53
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y2M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	36134000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	15112440
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.01
CY2021Q4	rklb	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.52
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	170320000
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9642000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	359000
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2427000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1520000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	441000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5276000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3388000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	329000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	336000
CY2023Q4	rklb	Total Lease Liabilities Current TotalLeaseLiabilitiesCurrent	5605000
CY2022Q4	rklb	Total Lease Liabilities Current TotalLeaseLiabilitiesCurrent	3724000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56099000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34266000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15238000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15568000
CY2023Q4	rklb	Total Lease Liabilities Non Current TotalLeaseLiabilitiesNonCurrent	71337000
CY2022Q4	rklb	Total Lease Liabilities Non Current TotalLeaseLiabilitiesNonCurrent	49834000
CY2023Q4	rklb	Lease Liability LeaseLiability	76942000
CY2022Q4	rklb	Lease Liability LeaseLiability	53558000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	7164000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	5107000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	3356000
CY2023	rklb	Amortization Of Favorable Lease AmortizationOfFavorableLease	610000
CY2022	rklb	Amortization Of Favorable Lease AmortizationOfFavorableLease	0
CY2021	rklb	Amortization Of Favorable Lease AmortizationOfFavorableLease	0
CY2023	rklb	Operating Lease Costs OperatingLeaseCosts	7774000
CY2022	rklb	Operating Lease Costs OperatingLeaseCosts	5107000
CY2021	rklb	Operating Lease Costs OperatingLeaseCosts	3356000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	627000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	562000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	967000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	900000
CY2023	rklb	Finance Lease Cost FinanceLeaseCost	1594000
CY2022	rklb	Finance Lease Cost FinanceLeaseCost	1462000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	6581000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4558000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3051000
CY2023	rklb	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	967000
CY2022	rklb	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	900000
CY2021	rklb	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	0
CY2023	rklb	Finance Cash Flows From Finance Leases FinanceCashFlowsFromFinanceLeases	336000
CY2022	rklb	Finance Cash Flows From Finance Leases FinanceCashFlowsFromFinanceLeases	271000
CY2021	rklb	Finance Cash Flows From Finance Leases FinanceCashFlowsFromFinanceLeases	0
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	30396000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9140000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3916000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P18Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P19Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.062
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.062
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8985000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Next Rolling Twelve Months FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths	1278000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9372000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	1201000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9366000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	1231000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9024000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	1262000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8095000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Five FinanceLeaseLiabilityPaymentsDueInRollingYearFive	1293000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	38375000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	20824000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	83217000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	27089000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21842000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	11522000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	61375000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	15567000
CY2023Q2	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	4066000
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	8047000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-205334000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-186121000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-132585000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	26413000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	53175000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	7745000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-178921000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-132946000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-124840000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-18000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-39000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3270000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3802000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2377000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3252000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3763000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2379000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	114000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2073000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5957000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	452000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-173000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-339000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	168000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1481000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3603000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-398000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	765000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9899000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3650000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2998000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7520000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	rklb	State Taxes Net Of Federal Benefit Percentage StateTaxesNetOfFederalBenefitPercentage	0.032
CY2022	rklb	State Taxes Net Of Federal Benefit Percentage StateTaxesNetOfFederalBenefitPercentage	0.083
CY2021	rklb	State Taxes Net Of Federal Benefit Percentage StateTaxesNetOfFederalBenefitPercentage	0.012
CY2023	rklb	Transaction Costs Percentage TransactionCostsPercentage	0
CY2022	rklb	Transaction Costs Percentage TransactionCostsPercentage	0.014
CY2021	rklb	Transaction Costs Percentage TransactionCostsPercentage	-0.002
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.006
CY2023	rklb	Uncertain Tax Positions Percentage UncertainTaxPositionsPercentage	-0.007
CY2022	rklb	Uncertain Tax Positions Percentage UncertainTaxPositionsPercentage	-0.021
CY2021	rklb	Uncertain Tax Positions Percentage UncertainTaxPositionsPercentage	0
CY2023	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0
CY2022	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.021
CY2021	rklb	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	-0.019
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.005
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.065
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.019
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.017
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.271
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.392
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.154
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.023
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.06
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2434000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2031000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1536000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1461000
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	22293000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	15361000
CY2023Q4	rklb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	20394000
CY2022Q4	rklb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	14064000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	4428000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	5341000
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4291000
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4039000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	87946000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	75765000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4768000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	870000
CY2023Q4	rklb	Reserves Reserves	2298000
CY2022Q4	rklb	Reserves Reserves	4285000
CY2023Q4	rklb	Capitalized Research CapitalizedResearch	52019000
CY2022Q4	rklb	Capitalized Research CapitalizedResearch	26953000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	462000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	885000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	202869000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	151055000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	173441000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125033000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	29428000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26022000
CY2023Q4	rklb	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-19232000
CY2022Q4	rklb	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	-13313000
CY2023Q4	rklb	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	-6402000
CY2022Q4	rklb	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	-7296000
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	719000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1609000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	26353000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	22218000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3075000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3804000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	173441000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125033000
CY2023	us-gaap	Federal State And Local Income Tax Expense Benefit Continuing Operations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0
CY2022	us-gaap	Federal State And Local Income Tax Expense Benefit Continuing Operations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2228000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3560000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	835000
CY2023	rklb	Unrecognized Tax Benefits Increase Related To Prior Year Tax Positions UnrecognizedTaxBenefitsIncreaseRelatedToPriorYearTaxPositions	0
CY2022	rklb	Unrecognized Tax Benefits Increase Related To Prior Year Tax Positions UnrecognizedTaxBenefitsIncreaseRelatedToPriorYearTaxPositions	1121000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	35000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1327000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1639000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4887000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3560000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	4087000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2760000
CY2023	rklb	Uncertain Tax Positions UncertainTaxPositions	3947000
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	352000000
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	317164000
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	57135000
CY2023	rklb	Carryforwards Expiration Year CarryforwardsExpirationYear	2034
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	24586000
CY2022Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	24532000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-182571000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-135944000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-117320000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	481768060
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	481768060
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	466214095
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	466214095
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	209895135
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	209895135
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244592000
CY2023	rklb	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	210996000
CY2022	rklb	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	62237000
CY2021	rklb	Percentage Of Total Revenue PercentageOfTotalRevenue	1
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0

Files In Submission

Name	View Source	Status
0000950170-24-022160-index-headers.html	Edgar Link	pending
0000950170-24-022160-index.html	Edgar Link	pending
0000950170-24-022160.txt	Edgar Link	pending
0000950170-24-022160-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img160632873_0.jpg	Edgar Link	pending
img160632873_1.jpg	Edgar Link	pending
img261563484_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
rklb-20231231.htm	Edgar Link	pending
rklb-20231231.xsd	Edgar Link	pending
rklb-ex10_29.htm	Edgar Link	pending
rklb-ex21_1.htm	Edgar Link	pending
rklb-ex23_1.htm	Edgar Link	pending
rklb-ex31_1.htm	Edgar Link	pending
rklb-ex31_2.htm	Edgar Link	pending
rklb-ex32_1.htm	Edgar Link	pending
rklb-ex4_2.htm	Edgar Link	pending
rklb-ex97.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rklb-20231231_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RKLB
Rocket Lab USA, Inc. Stock $rklb

2024 Q1 Form 10-K Financial Statement

#000095017024022160 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RKLB Rocket Lab USA, Inc. Stock $rklb

2024 Q1 Form 10-K Financial Statement

#000095017024022160 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RKLB
Rocket Lab USA, Inc. Stock $rklb